If you are suffering from heel pain, you’re not alone. According to foot and ankle surgeons attending the 68th Annual Scientific Conference of the American College of Foot and Ankle Surgeons in Las Vegas this week, heel pain continues to be the most common reason patients seek care. Surgeons advise the best defense to keeping pain in control is early treatment…
Read more about Heel Pain Continues To Plague Adults
MicroTransponder, Inc., a privately-held medical device company, has just announced a $7 Million Series B round of funding. MicroTransponder is developing a wireless neurostimulation platform for the treatment of chronic pain and other neurological indications. In addition, the Company is announcing that it has been awarded a $2…
Read more about MicroTransponder Raises $10 Million To Begin Clinical Trials Of Wireless Neurostimulation For Chronic Pain And Obtain FDA Clearance
Medical device company Vertos Medical Inc. has reported that an observational study on mild*, published in the January/February 2010 issue of the peer-reviewed journal Pain Physician, has demonstrated the acute safety of the procedure in the treatment of lumbar spinal stenosis (LSS).1 The study, conducted by leading pain physicians Timothy Deer, M.D…
Read more about Acute Study Demonstrates Safety Of Vertos Medical’s Mild(R) Procedure; Findings Appear In Pain Physician Journal
People can reduce their sensitivity to pain by thickening their brain, according to a new study published in a special issue of the American Psychological Association journal, Emotion. Researchers from the Universite de Montreal made their discovery by comparing the grey matter thickness of Zen meditators and non-meditators…
Read more about Thicker Brains Fend Off Pain
Orexo AB (STO:ORX) announces that its partner Kyowa Hakko Kirin Co., Ltd. has submitted the New drug Application (NDA) in Japan for the cancer pain drug KW-2246 (Abstral). Kyowa Hakko Kirin has confirmed KW-2246′s safety and efficacy in clinical trials conducted in Japan. The drug will be marketed by Kyowa Hakko Kirin and Hisamitsu Pharmaceutical Co., Inc…
Read more about Orexo Announces Kyowa Hakko Kirin’s Submission Of KW-2246 (Abstral) For Approval In Japan
DEAR DR. DONOHUE: I have played in a men’s basketball league for the past five years.
Read more about Tendon is athlete’s weak spot
Heres why we have those tip-of-the-tongue moments Remember scratching your head when you couldnt recall the word you intended to use and it kept hanging at the tip of your tongue but never came out? Well, researchers have offered to explain the reason behind the annoying phenomenon.
Read more about Hypnosis may help control pain among metastatic breast cancer patients
A treatment designed to challenge how people with low back pain think about their condition and change their behaviors was shown to have long-term benefits in a newly published study.
Read more about Talk Therapy May Treat Low Back Pain
Initial treatment with twice weekly etanercept , a tumour necrosis factor antagonist, achieves more rapid clearance of skin lesions than once weekly treatment in patients with active psoriasis and psoriatic arthritis, according to results from the PRESTA study reported recently in the British Medical Journal .
Read more about Study Shows Twice Weekly Etanercept Clears Psoriasis Lesions More Quickly Than Once Weekly Treatment
Back pain is an all-too-common problem. If you’ve been putting up with chronic back pain, talk with your doctor.
Read more about Prevent chronic back pain flare-ups
